EP Patent

EP1866012A1 — Needle-free injection device

Assigned to Bioject Inc · Expires 2007-12-19 · 18y expired

What this patent protects

The disclosure provides a filling cap for use in a needle-free injection system. The filling cap includes a vial-engagement portion and an ampule-engagement portion with a frangible portion extending therebetween. The vial-engagement portion is designed to removably engage a vial…

USPTO Abstract

The disclosure provides a filling cap for use in a needle-free injection system. The filling cap includes a vial-engagement portion and an ampule-engagement portion with a frangible portion extending therebetween. The vial-engagement portion is designed to removably engage a vial of to be transferred into an ampule, and the ampule-engagement portion is designed to nonremovably engage an ampule.

Drugs covered by this patent

Patent Metadata

Patent number
EP1866012A1
Jurisdiction
EP
Classification
—
Expires
2007-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Bioject Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.